The California Institute of Quantitative Biosciences (QB3) founded Mission Bay Capital in 2009 to provide venture capital to startups at the University of California. Mission Bay Capital is a venture capital firm making seed and early stage investments in startup technology companies typically operating within the industries of biotechnology and life science. The firms head office is located in San Francisco, California. Notable exits made by Mission Bay Capital include: Calithera Biosciences, iPierian, Redwood Bioscience, and Zephyrus Biosciences.
Wild Type is a San Francisco based company producing meat products like salmon using cellular agriculture lab techniques.
A company dedicated on the discovery and development of small molecule therapeutics to treat cancer
A biopharmaceutical company developing oral small molecule therapies for the treatment of cancer and autoimmune diseases
GraphWear Technologies is a San Francisco-based company.
ViewPoint Therapeutics is a San Francisco-based company.
SiteOne Therapeutics is a Bozeman, Montana-based company.
Associated investment funds
Harold E. Selick
John Wadsworth, Jr
Peter D. Parker
Managing General Partner
Mission Bay Capital Fund Launches - PE Hub
Mission Bay Capital Raising $85 Million for Life Science Startups
QB3's Mission Bay Capital Closes $25M Fund II
Small but mighty VC doubles up with new biotech seed fund
Documentaries, videos and podcasts
Scientific Research Tools